Our Clinical Trial Experience With Tuberculosis
The FHI Clinical project team has partnered with companies to conduct clinical trials as well as epidemiological and observational studies for tuberculosis in 30 countries worldwide.
Our Clinical Trial Experience With HIV
The FHI Clinical project team has partnered with companies to conduct clinical trials as well as behavioral and observational studies for HIV in 24 countries worldwide.
Our Clinical Trial Experience With Malaria
For more than 10 years, the FHI Clinical project team has partnered with companies developing and deploying vaccines, treatments and preventive devices for malaria in more than 35 countries worldwide.
Our Experience in sub-Saharan Africa
FHI Clinical has long-standing relationships, a local team and broad expertise in sub-Saharan Africa. We're ready to help you confidently expand your research across the region, finding the best-fit countries and populations for your target indication and study type.
About FHI Clinical
FHI Clinical goes where our expertise is needed. Whether it requires working from a state-of-the-art facility or in a low-tech, rural setting, we provide services tailored to meet your study needs, from protocol design and site assessments to trial planning, implementation and management.
Our Clinical Trial Experience With Oncology
For nearly 20 years, the FHI Clinical project team has partnered with companies developing and deploying vaccines, treatments and diagnostic tests for multiple oncology indications.
Project Profile: COVID-19 Study in Ghana
Investigating existing treatments for their efficacy to treat COVID-19 is important in some countries with limited access to new treatments, such as Ghana. In this project profile, Loice Magaria, Clinical Research Project Manager at FHI Clinical, discusses a study we’re supporting in Ghana to investigate COVID-19 treatments.
Final Thoughts on the Trip to Visit the PREVAIL Network in Liberia
In this video, FHI Clinical experts share their final thoughts following a fall 2021 trip to Liberia to visit the PREVAIL network of sites and staff.
What’s Next for the PREVAIL Network?
Watch this video to hear FHI Clinical experts detail upcoming research projects the PREVAIL network is excited to embark on, including a Lassa fever program.
COVID-19 Impact on the Liberian Healthcare Systems
FHI Clinical experts discuss their observations on the effects of COVID-19 on the local healthcare system during their fall 2021 visit to the Liberian PREVAIL sites.
